Skip to Content
Is technology key to beating breast cancer? Learn more >

Medications for Breast Cancer, Adjuvant

What is Breast Cancer, Adjuvant:  Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.

Medications to treat Breast Cancer, Adjuvant

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Femara D N 7 reviews
7.0

Generic name: letrozole systemic

Drug class: hormones/antineoplastics, aromatase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
tamoxifen D N 3 reviews
8.0

Generic name: tamoxifen systemic

Brand name:  Soltamox

Drug class: hormones/antineoplastics, selective estrogen receptor modulators

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Herceptin D N 2 reviews
9.0

Generic name: trastuzumab systemic

Drug class: HER2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
letrozole D N 11 reviews
5.0

Generic name: letrozole systemic

Brand name:  Femara

Drug class: hormones/antineoplastics, aromatase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Taxol D N Add review Rate

Generic name: paclitaxel systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Soltamox D N Add review Rate

Generic name: tamoxifen systemic

Drug class: hormones/antineoplastics, selective estrogen receptor modulators

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
epirubicin D N X Add review Rate

Generic name: epirubicin systemic

Brand names:  Ellence, Pharmorubicin PFS

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
leuprolide Off Label X N 1 review
2.0

Generic name: leuprolide systemic

Drug class: hormones/antineoplastics, gonadotropin releasing hormones

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
paclitaxel D N Add review Rate

Generic name: paclitaxel systemic

Brand name:  Taxol

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
trastuzumab D N 2 reviews
9.0

Generic name: trastuzumab systemic

Brand name:  Herceptin

Drug class: HER2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Ellence D N X Add review Rate

Generic name: epirubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Pharmorubicin PFS D N X Add review Rate

Generic name: epirubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

 
neratinib U Add review Rate

Generic name: neratinib systemic

Brand name:  Nerlynx

Drug class: EGFR inhibitors, HER2 inhibitors

For consumers: interactions, side effects

 
Nerlynx U Add review Rate

Generic name: neratinib systemic

Drug class: EGFR inhibitors, HER2 inhibitors

For consumers: interactions, side effects

For professionals: Prescribing Information

 

Learn more about Breast Cancer, Adjuvant

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide